A PROSPECTIVE RANDOMIZED TRIAL COMPARING INTERLEUKIN-2 RECEPTOR ANTIBODY VERSUS ANTITHYMOCYTE GLOBULIN AS PART OF A QUADRUPLE IMMUNOSUPPRESSIVE INDUCTION THERAPY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION

199760 citationsJournal Article

Authors

Jan M. Langrehr

Natascha C. N ssler

H. Schlag · Biotest (Germany)

Abstract

Our results indicate that treatment with anti-interleukin-2 receptor antibody as part of quadruple induction therapy after orthotopic liver transplantation is safe and effective and shows fewer steroid-sensitive rejection episodes as well as fewer side effects when compared with quadruple induction therapy including ATG.

Topics & Keywords

Organ Transplantation Techniques and Outcomes Liver Disease and Transplantation Renal Transplantation Outcomes and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Transplantation

Volume 63, Issue 12, pp. 1772-1781

DOI: 10.1097/00007890-199706270-00012

Field-Weighted Citation Impact: 7.56